North American Neural Implants Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027

The North American neural implants market is estimated to grow at a CAGR of 8.5% during the forecast period. North America is dominating the global neural implants market owing to the high prevalence of neurological disorders and technological innovations in the neural/brain implant devices. The growth in the region is mainly attributed to the increasing incidence of PD, chronic pain, epilepsy, and conditions such as obesity, depression, and a rise in surgical procedures for treating such diseases. Furthermore, the availability of advanced healthcare infrastructure and constant technological innovations, and growing acceptance for technologically advanced neural implants are also accelerating the market growth in the region.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/north-american-neural-implants-market

Further, epidemiological studies reported, an estimated 60,000 Americans are diagnosed with PD every year. Studies have also estimated, about one million people in the US alone will be living with PD by the end of 2020. In addition, the National Center for Health Statistics reported, around 25% of American adults suffer from chronic LBP. Also, according to the CDC, in 2016, approximately 20.4% of the US adults had chronic pain, and 8.0% of the US adults suffered from high-impact chronic pain with higher prevalence associated with the increasing age of the population.

Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/north-american-neural-implants-market

The North American neural implants market is segmented based on product, application, and end-user. Based on the product, the neural implants market is segmented deep brain stimulation (DCS), spinal cord stimulation (SCS), and vagus nerve stimulation (VNS). Based on application, the market is classified into Chronic Pain, Epilepsy, Parkinson's Disease (PD), and others (depression and other movement disorders). Based on end-user, the market is segmented into hospitals, outpatient surgery centers, and specialized neurological centers (SNCs).

Further, vendors are focusing on developing innovative and advanced products that will offer improved treatment outcomes using neural implants. HCPs are recommending treatment for PD, chronic pain, and other neural disorders using neural implants such as DBD, SCS, and VNS. Therefore, the accuracy and effectiveness of neural implants to reduce the risks of neurological disorders is influencing the neural implants market in North America.

Market Segmentation
North American Neural Implants Industry Market by Product
• Deep Brain Stimulation (DCS)
• Spinal Cord Stimulation (SCS)
• Vagus Nerve Stimulation (VNS)

North American Neural Implants Market by Application
• Chronic Pain
• Epilepsy
• Parkinson's Disease (PD)
• Others (Depression and Other Movement Disorders)

North American Neural Implants Market by End-user
• Hospitals
• Outpatient Surgery Centers
• Specialized Neurological Centers (SNCs)

Regional Analysis
• The US
• Canada

Company Profiles
• Abbott
• Boston Scientific Corporation
• Functional Neuromodulation Ltd.
• LivaNova PLC
• Medtronic
• Nalu Medical, Inc.
• NEVRO CORP.
• NEURALINK*
• NeuroPace, Inc.
• NeuroSigma, Inc.
• Nuvectra Medical
• Renishaw plc
• Saluda Medical Pty Ltd.
• SetPoint Medical Corp.*
• Stimwave LLC
• Synchron, Inc.*

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/north-american-neural-implants-market

Media Contact:
Company name: Orion Market Research
Contact person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.